It’s no secret that we’re on a little bit of an expansion bender these days (hey there, Boulder/Denver), and our next hit is going to be a big one: Xconomy Texas. With the combination of Houston’s first-class research hospitals and growing life sciences sector, Austin’s vibrant tech scene, and the state’s massive energy sector we … Continue reading “Wanted: Star Journalist to Help Launch Xconomy in the Lone Star State”
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
What Makes You Optimistic? Xconomists Chime In.
One of the great pleasures of helping to grow Xconomy over the last five-plus years has been getting to know the diverse and fascinating group of people we call the Xconomists, and getting to hang out with them at our various events around the country. And these last few months it has seemed that many … Continue reading “What Makes You Optimistic? Xconomists Chime In.”
Almost Time for Face Time with Sam Waksal, Kevin Kinsella, and More
Calendar double-take of the day: there are only two weeks left until our big New York biotech event—and your big chance to hang out with the likes of Sam Waksal and Kevin Kinsella. Waksal, of ImClone fame, and Kinsella, founder of Avalon Ventures, will join Cancer Research Institute CEO Jill O’Donnell-Tormey and Enumeral Biomedical CEO … Continue reading “Almost Time for Face Time with Sam Waksal, Kevin Kinsella, and More”
Calling All Boston-Area Marketing Mavens…
…or really just one great one: Xconomy needs your help. We’re busy cranking out terrific tech and life sciences journalism and putting on stellar events across the six cities in our network, and we’re looking for a kick-ass marketing coordinator to help us get the word out about all of it. Full details are here, … Continue reading “Calling All Boston-Area Marketing Mavens…”
Classing Up the Joint
Regular visitors to Xconomy.com may have noticed that we did some redecorating over the weekend. Our new look and feel, courtesy of the crazy talented Rob Hunter of True Italic in New York, is the first in a series of changes we’ll be making over the next few months—all aimed at making it easier and … Continue reading “Classing Up the Joint”
Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News
This week New England’s life sciences community saw a couple of cool new companies emerge and a few potentially important new treatments reach key milestones. —Boston-based Third Rock Ventures launched its newest startup with $35 million to develop a new class of drugs for brain disorders such as schizophrenia and depression. Sage Therapeutics’ approach is … Continue reading “Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News”
Oracle Scoops Up Endeca, Kleiner Perkins and Google Ventures Back Foundation Medicine, Care.com Collects $25M, & More Boston-Area Deals News
New England’s tech and life sciences companies have been inking deals all over the place this past week. First up, the big surprise… —Cambridge, MA-based Endeca Technologies, an enterprise search and e-commerce company that was founded in 1999, agreed to be acquired by Silicon Valley database and business software giant Oracle. Terms of the deal … Continue reading “Oracle Scoops Up Endeca, Kleiner Perkins and Google Ventures Back Foundation Medicine, Care.com Collects $25M, & More Boston-Area Deals News”
Xconomy and WGBH Team Up to Cover the Boston Innovation Economy
Boston area radio listeners may have noticed something pretty cool on Friday morning: Xconomy’s on-air debut, during “Morning Edition” on WGBH’s 89.7. The Xconomy Report segment, which will be a regular feature Fridays at 7:49 am, is the product of a new partnership between us and WGBH Radio. It should come as no surprise that several … Continue reading “Xconomy and WGBH Team Up to Cover the Boston Innovation Economy”
Knome Nabs $5M
A Cambridge, MA-based personal genomics company has raised $5 million from one investor in a round that could eventually total $20 million, according to a regulatory filing. Launched in 2007 by the famed Harvard geneticist George Church, Knome offers wealthy consumers the chance to have their entire genomes sequenced and analyzed by the company’s scientists. … Continue reading “Knome Nabs $5M”
Sarah Schmid Suits Up for Xconomy Detroit
Sarah Schmid’s high school and mine were rivals, but I’m not holding it against her. In fact, having a home-grown Michigan journalist take up the reins of Xconomy Detroit is so exciting I’m willing to overlook any number of gridiron defeats and any amount of adolescent cooler-than-thou posturing. Even more exciting is the fact that … Continue reading “Sarah Schmid Suits Up for Xconomy Detroit”
Xconomy’s New York Team Doubles in Size, Plots East Coast (Biotech) Takeover
It’s easy to forget that Arlene Weintraub, Xconomy New York’s editor, has been running a one-woman show since joining us in April. Sure she’s had loads of help from her colleagues across the Xconomy network. But still, the whole of New York tech and life sciences is a big monster of a beat for one … Continue reading “Xconomy’s New York Team Doubles in Size, Plots East Coast (Biotech) Takeover”
Today’s XSITEing Opportunity: Galaxy Tab 10.1 Giveaway
As if there weren’t already enough reasons to be looking forward to the June 16 Xconomy Summit on Innovation, Technology, and Entrepreneurship, today we’re adding a thin, shiny reason with HD video and front and rear cameras. We’re going to throw the names of the first 50 folks to register in June for XSITE 2011 into … Continue reading “Today’s XSITEing Opportunity: Galaxy Tab 10.1 Giveaway”
Xconomy to Tech Journalists: Help Us Take an Even Bigger Bite Out of the Big Apple
It’s been less than a month since we launched Xconomy New York, and (to none of our surprise, really) we’re already finding there are more important innovation stories than even Arlene Weintraub, the intrepid editor of Xconomy New York, can tell on her own. So to all you reporters pounding the pavement in NYC’s tech … Continue reading “Xconomy to Tech Journalists: Help Us Take an Even Bigger Bite Out of the Big Apple”
Gemvara Grabs $15M, RueLaLa Spins Off, Mobiquity Launches With $5M, & More Boston-Area Deals News
New England’s tech firms inked a bunch of deals this past week. Here are a few of them. —Gemvara raised $15 million in a Series C funding round led by London-based Balderton Capital and joined by return investors Highland Capital Partners and Canaan Partners. The Lexington, MA-based online jewelry customization startup, which has now raised … Continue reading “Gemvara Grabs $15M, RueLaLa Spins Off, Mobiquity Launches With $5M, & More Boston-Area Deals News”
Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News
New England’s biotech attorneys must be working overtime, if the week’s headlines are any indication. —Cambridge, MA-based Alnylam (NASDAQ:[[ticker:ALNY]]) announced it had settled a long-standing legal dispute over the so-called Tuschl I and Tuschl II patent families. The suit, which involved key players in the field of RNA-interference including Alnylam, Max Planck Society, the University … Continue reading “Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News”
HP Snaps Up Vertica, TechStars Bags $500K, Skyhook Partners With Intel and Citysearch, & More Boston-Area Deals News
Software, tech, and stealth dominated the week’s deals news. —TechStars Boston, the startup incubator program, raised about a quarter of a planned $2 million funding round. If completed, the round will reportedly support the program through 2014. —Palo Alto, CA-based Hewlett-Packard (NYSE: [[ticker:HPQ]]) acquired Vertica, the Billerica, MA-based database management and analytics software firm, for … Continue reading “HP Snaps Up Vertica, TechStars Bags $500K, Skyhook Partners With Intel and Citysearch, & More Boston-Area Deals News”
Meritage Swallows $2M
San Diego-based drug developer Meritage Pharma raised $2 million in a round of equity-based financing planned to total $5.5 million, an SEC filing indicates. Meritage is out to develop a treatment for a little-known ailment called eosinophilic esophagitis, in which an allergic reaction causes a patient’s esophagus to swell, sometimes to the point where food becomes … Continue reading “Meritage Swallows $2M”
Introducing Tom Lee–He May Need a Nap, But He’s Never Too Tired To Talk About Innovation
Southeast Michigan, please be kind to Tom Lee. Thanks to some lame, opaque rues at an airline which shall remain nameless, the newest addition to the Xconomy team—who starts today as our Detroit editor and national med tech editor—endured a 10 hour drive this weekend instead of the two-hour flight he was expecting. But weary … Continue reading “Introducing Tom Lee–He May Need a Nap, But He’s Never Too Tired To Talk About Innovation”
$12.7M Blows in for Wind Power Holdings, Epizyme Forges Alliance with GlaxoSmithKline, & Many More Boston-Area Deals
Dealmaking activity in New England’s tech and life sciences sectors continued at a blizzardy pace this week. Hold on to your hat… —Marlborough, MA-based biofuels developer Qteros raised $22 million from new and existing investors in the first tranche of a Series C financing. —IT services provider MindShift Technologies of Waltham, MA, acquired Alpheon, a … Continue reading “$12.7M Blows in for Wind Power Holdings, Epizyme Forges Alliance with GlaxoSmithKline, & Many More Boston-Area Deals”
Start Spreading the (Innovation) News With Xconomy in New York
I’ve got Frank Sinatra on endless mental replay today and I’ll tell you why: I’m looking for a stellar journalist to start spreading the news about innovation in New York, New York. (Look, nobody’s groaning louder than me about that one. Let’s move on…) My Xconomy colleagues and I are fascinated by the stories emerging … Continue reading “Start Spreading the (Innovation) News With Xconomy in New York”
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News
2001 is off to a running start for dealmakers in New England’s tech and life sciences sectors, it seems. —Cambridge, MA-based Genocea Biosciences pulled in a tidy $35 million in a Series B funding round. The vaccine developer, a spinout of Harvard, saw contributions from new investors Johnson & Johnson Development Corporation, MP Healthcare Venture … Continue reading “SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News”
DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News
New England’s life sciences companies headed into the holiday break with mostly good news. —Syndax Pharmaceuticals reported results from a mid-stage clinical trial which suggest that its lead drug, entinostat, might help lung certain cancer patients with a particular molecular marker live longer. The Waltham, MA-based startup, co-founded by researchers from the Salk Institute for … Continue reading “DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News”
BG Medicine Eyes $70M IPO, Nano-Terra Picks Up $17.2M, Rive Technology Raises $25M, & More Boston-Area Deals News
Lots of nice deals to report this week from New England’s tech and life sciences sectors. —E-mail archiving provider Sonian indicated to the SEC that it had raised $4 million in an equity offering that could total $9 million. Previous backers of the Needham, MA-based firm include Prism VentureWorks and Summerhill Venture Partners. —BG Medicine … Continue reading “BG Medicine Eyes $70M IPO, Nano-Terra Picks Up $17.2M, Rive Technology Raises $25M, & More Boston-Area Deals News”
SmartCells Finds Potential $500M+ Exit, EnerNOC Acquires Global Energy Partners, Azuki Adds $4M, & More Boston-Area Deals News
New England’s tech and life sciences companies were busy this week. Here are some of the deals they inked. —Waltham, MA-based research tools and services provider Thermo Fisher Scientific (NYSE:[[ticker:TMO]]) announced plans to buy Lomb Scientific—an Australian maker of lab chemicals, consumables, and instruments—for an undisclosed sum. —LineSider Technologies, a Danvers, MA-based maker of network management … Continue reading “SmartCells Finds Potential $500M+ Exit, EnerNOC Acquires Global Energy Partners, Azuki Adds $4M, & More Boston-Area Deals News”
Heartland Reaps $20M, CloudBees Gathers $4M, Adimab Acquires $4M, & More Boston-Area Deals News
A number of New England tech and life sciences companies had deals to be thankful for this week. —CloudBees, a startup soon to be headquartered in Boston, raised $4 million in a Series A financing round led by Matrix Partners. Individual investors Marc Fleury and Bob Bickel also backed CloudBees, which is developing a cloud-based … Continue reading “Heartland Reaps $20M, CloudBees Gathers $4M, Adimab Acquires $4M, & More Boston-Area Deals News”
EMC Shells Out $2.25B for Isilon, Cerulean Secures $24M, Kayak Files for IPO, & More Boston-Area Deals News
This week saw deals inked in all corners of New England’s innovation ecosystem, but the biggie was in IT. —Regulatory filings indicate that Kala Pharmaceuticals raised $3 million in an equity and debt financing. The Waltham, MA-based startup, which raised $2 million in December 2009, counts MIT inventor Bob Langer and representatives of Lux Capital, … Continue reading “EMC Shells Out $2.25B for Isilon, Cerulean Secures $24M, Kayak Files for IPO, & More Boston-Area Deals News”
Oracle Buys ATG for $1B, Acquia Raises $8.5M, Boston Scientific Sells Unit to Stryker for $1.5B, & More Boston-Area Deals News
If you like deals with a “billion” in them, this was the week for you. —Software maker Neohapsis of Cambridge, MA, raised $4.5 million in a deal led by New Venture Partners and joined by return backers Trident Capital and Paladin Capital Group. Neohapsis, which targets the governance, risk, and compliance market, also acquired the … Continue reading “Oracle Buys ATG for $1B, Acquia Raises $8.5M, Boston Scientific Sells Unit to Stryker for $1.5B, & More Boston-Area Deals News”
Novartis to Invest $600M in Cambridge Complex
Swiss pharma behemoth Novartis, already Cambridge, MA’s biggest corporate employer, planns to invest $600 million more in a new 4 acre office and lab complex here, according to a report on the Boston Globe website. As part of a plan to strengthen its global research operations, which have been headquartered in Cambridge since 2002, Novartis expects … Continue reading “Novartis to Invest $600M in Cambridge Complex”
Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News
Dealmaking activity was on the light side this week in the New England tech and life sciences sectors, but there are still some interesting items to report. —Search-engine developer Goby raised $2.5 million from Kepha Partners and Flybridge Capital Partners, both return investors. The Boston-based startup is taking a local-search approach to helping people find … Continue reading “Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News”
Find The Investor of Your Dreams—For Free
There’s all sorts of wisdom about how to find folks to invest in your startup, ranging from the obvious to the slightly stalkerish. Approach investors who’ve supported companies like yours in the past. Go to startup school. Wait until a famous VC is stranded somewhere and give him a lift. In some ways, the most … Continue reading “Find The Investor of Your Dreams—For Free”
Spark Capital Gathers $360M Worth of Kindling, 1366 Technologies Nabs $20M, NinePoint Medical Pinpoints $33M, & More Boston-Area Deals News
IT companies dominated this week’s deals news in New England. Here are some highlights. —Online videogame maker Quick Hit raised $2.5 million in equity financing, according to an SEC filing. The Foxborough, MA-based startup, which has a deal with the National Football League to used official team names, logos, and uniforms for its football role-playing … Continue reading “Spark Capital Gathers $360M Worth of Kindling, 1366 Technologies Nabs $20M, NinePoint Medical Pinpoints $33M, & More Boston-Area Deals News”
Marvell Backs OLPC Tablet With $5.6M, Sanofi-Aventis’ Makes Takeover Bid for Genzyme, $7M Lands in The Echo Nest, & More Boston-Area Deals News
A French drugmaker’s bid to acquire one of New England’s biggest biotechs turned hostile this week. Read on for this, and some of the week’s less predictable deals news from the tech and life sciences sectors. —Watertown, MA-based WiTricity forged an alliance with Troy, MI-based Delphi Automotive aimed at developing wireless charging stations for hybrid … Continue reading “Marvell Backs OLPC Tablet With $5.6M, Sanofi-Aventis’ Makes Takeover Bid for Genzyme, $7M Lands in The Echo Nest, & More Boston-Area Deals News”
Merck Ends Aveo Deal, Acceleron Rides Pharma Partnership Wave, Rhythmia Raises $5M, & More Boston-Area Life Sciences News
The birth and death of partnerships was the subject of much of this week’s news in New England’s life sciences sector. —Rhythmia Medical raised $5 million in an equity offering that could end up being worth $7 million, according to a regulatory filing, bringing the Burlington, MA-based startup’s total funding to $17 million. Rhythmia is … Continue reading “Merck Ends Aveo Deal, Acceleron Rides Pharma Partnership Wave, Rhythmia Raises $5M, & More Boston-Area Life Sciences News”
Novartis Edges Out Biogen Idec in Oral MS Drug Race, Ironwood Sells Microbia to DSM, RXi Teams With Eyegate, & More Boston-Area Life Sciences News
It was New England’s public life sciences companies that made the most news in the sector this week. —Ryan chatted with Mark Corrigan, CEO of Zalicus (NASDAQ: [[ticker:ZLCS]]), about the Cambridge, MA-based company’s efforts to rebuild its image among investors after a long period of upheaval. Originally known as CombinatoRx, the firm has seen the … Continue reading “Novartis Edges Out Biogen Idec in Oral MS Drug Race, Ironwood Sells Microbia to DSM, RXi Teams With Eyegate, & More Boston-Area Life Sciences News”
IBM Acquires Netezza and OpenPages, Boston Scientific Buys Asthmatx, Massachusetts Startup Financing Rebounds, & More Boston-Area Deals News
Big Blue is gobbling up all of New England’s IT companies—or at least that’s the impression you’d get from this week’s deals news. —IBM (NYSE: [[ticker:IBM]]) announced it will acquire Waltham, MA-based OpenPages for an undisclosed sum. The Waltham firm, whose backers include Goldman Sachs, Globespan Capital Partners, Matrix Partners, Mesirow Financial, Sigma Partners, and … Continue reading “IBM Acquires Netezza and OpenPages, Boston Scientific Buys Asthmatx, Massachusetts Startup Financing Rebounds, & More Boston-Area Deals News”
Ironwood Drug Passes Clinical Test, Genzyme Cuts Jobs and Sheds Business Unit, Third Rock Closes $426M Fund, & More Boston-Area Life Sciences News
All eyes continued to be on Genzyme this week, but other New England life sciences companies had interesting developments to report as well. —Good Start Genetics, a three-year-old Boston startup built in part around technology from the Harvard lab of George Church, completed an $18 million Series A round of funding from OrbiMed Advisors, Safeguard … Continue reading “Ironwood Drug Passes Clinical Test, Genzyme Cuts Jobs and Sheds Business Unit, Third Rock Closes $426M Fund, & More Boston-Area Life Sciences News”
Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News
New England’s life sciences companies inked the majority of this week’s deals, but several software firms had interesting business to report as well. —Boston-based startup Rhythm Pharmaceuticals completed its Series A financing round with a total of $40 million. Third Rock Ventures participated in the closing, joining MPM Capital and New Enterprise Associates, who led … Continue reading “Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News”
Pfizer Axes Celldex Agreement, Vertex’s Telaprevir Performs in Clinical Trial, Anchor Therapeutics Inks Potential $480M Deal With J&J, & More Boston-Area Life Sciences News
—Needham, MA-based Celldex Therapeutics announced that Pfizer (NYSE: [[ticker:PFE]]) had terminated a agreement in which it licensed Celldex’s experimental cancer vaccine rindopepimut, because it no longer views the drug as a strategic priority. Celldex (NASDAQ: [[ticker:CLDX]]) will regain full rights to develop and commercialize the drug, effective November 1. —Ryan checked in with Oliver Fetzer, … Continue reading “Pfizer Axes Celldex Agreement, Vertex’s Telaprevir Performs in Clinical Trial, Anchor Therapeutics Inks Potential $480M Deal With J&J, & More Boston-Area Life Sciences News”
PrimeraDx Names New CEO
PrimeraDx, a Mansfield, MA-based developer of molecular diagnostic technology, has named Matthew F. McManus as its new president and chief executive, the company announced today. The startup, which raised $20 million in a series C financing last fall, said it’s gearing up to bring to market the first of its products, which are aimed at … Continue reading “PrimeraDx Names New CEO”
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News
[Updated 8/13/2010 9:30 EST. See below.] New England’s biotech and healthcare sector yielded a number of interesting stories this week. —Joanna Horobin, CEO of Syndax Pharmaceuticals, confirmed that the Waltham, MA-based cancer-drug developer has raised $6 million in a convertible debt financing round planned to total $7 million. The new funds will support a clinical … Continue reading “Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News”
Blue Cod and Viridity Bag $8M Apiece, Aprendica and Arbor Networks Acquired, & More Boston-Area Deals News
New England’s tech and life sciences firms had a busy week raising money and inking acquisition deals. So much for the summer slow-down! —Blue Cod Technologies announced it has raised $8 million in a follow-on financing led by General Electric Pension Trust. Edison Venture Fund, a previous investor in the Marlborough, MA-based provider of outsourcing … Continue reading “Blue Cod and Viridity Bag $8M Apiece, Aprendica and Arbor Networks Acquired, & More Boston-Area Deals News”
Sylvia Pagán Westphal Takes the Pulse of Life Sciences for Xconomy
One of the things I’ve always enjoyed about technology journalism is how cozy a niche it is. There just aren’t than many folks who can geek out with the lab dwellers, put the hard questions to the executives, and get it all down on the page, on a deadline–so it often feels like if you … Continue reading “Sylvia Pagán Westphal Takes the Pulse of Life Sciences for Xconomy”
$10M for Akorri, $52M for Dyax, A New Partner for Dicerna, & More Boston-Area Deals News
The precipitation in New England may have reached near-biblical proportions this past week, but tech and life sciences deal making was more modest. —Investors poured $10.1 million into Littleton, MA-based software maker Akorri Networks, according to an SEC filing. The filing did not reveal the identity of the 13 backers involved in the equity-based round, … Continue reading “$10M for Akorri, $52M for Dyax, A New Partner for Dicerna, & More Boston-Area Deals News”
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News
This week saw new leadership at a couple of New England’s life sciences companies, some wisdom from one of its newly public companies, and a new truce in one of its long-running power struggles. —Luke tracked down close to 200 alumni of legendary Boston-area biotech firm Genetics Institute, which was acquired in 1996 by Wyeth. … Continue reading “Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News”
Genetix Gets $35M for Gene Therapy, FDA Delays Decision on Alkermes/Amylin Drug, MedMinder and Vitality Tackle Medication Compliance, & More Boston-Area Life Sciences News
The FDA added some suspense to one New England biotech firm’s week, while two others reached closure on nice-sized venture deals. —Genetix Pharmaceuticals raised $35 million in a Series B round of venture capital from new investors Third Rock and Genzyme Ventures and return backers Easton Capital, Forbion Capital Partners, and TVM Capital. Ryan took … Continue reading “Genetix Gets $35M for Gene Therapy, FDA Delays Decision on Alkermes/Amylin Drug, MedMinder and Vitality Tackle Medication Compliance, & More Boston-Area Life Sciences News”
Vertex Pursues Drug-Cocktail Strategy, Phase Forward Out To Expand Health IT Empire, Alkermes Awaits FDA Ruling, & More Boston-Area Life Sciences News
Another week, another cadre of CEOs with big plans for growing their New England life sciences companies even bigger. —Diagnostics For All CEO Una Ryan talked about her multi-pronged effort to raise money for testing and deployment of her Cambridge, MA-based firm’s affordable diagnostic technology. Developed in the legendary Harvard lab of chemist George Whitesides, … Continue reading “Vertex Pursues Drug-Cocktail Strategy, Phase Forward Out To Expand Health IT Empire, Alkermes Awaits FDA Ruling, & More Boston-Area Life Sciences News”
Elliott Makes $2B Bid for Novell, Summit Partners Leads $23M Investment in Cloudmark, Stemgent Backs Scottish Startup, & More Boston-Area Deals News
Deal flow was a bit slow among New England’s tech and life sciences firms this week. Perhaps folks were too distracted by the unexpected appearance of that warm glowing ball in the sky to attend to contracts and negotiations? —Stemgent of Cambridge, MA, and San Diego announced plans to invest $4.5 million over the next … Continue reading “Elliott Makes $2B Bid for Novell, Summit Partners Leads $23M Investment in Cloudmark, Stemgent Backs Scottish Startup, & More Boston-Area Deals News”
Biogen Idec Seeks Science-Savvy CEO, LifeImage Partners With EMC, GenomeQuest Aims to be Genetic Google, & More Boston-Area Life Sciences News
Another eventful week for New England’s life sciences companies, with big changes potentially in store for two of the biggest firms. —Biogen Idec’s new board chairman, Bill Young, told Luke that the committee tasked with finding a replacement for outgoing CEO Jim Mullen is first and foremost looking for somebody “who has managed and understands … Continue reading “Biogen Idec Seeks Science-Savvy CEO, LifeImage Partners With EMC, GenomeQuest Aims to be Genetic Google, & More Boston-Area Life Sciences News”
Luminus Devices Nabs $19M, Aveo Sets IPO Range, Thermo Fisher Scientific Reportedly Makes $6 B Move on Millipore, & More Boston-Area Deals News
It was a good week for venture dealmaking among New England’s tech and life sciences firms. —Needham, MA-based Stata Venture Partners led a $7 million Series B financing round for NABsys, a Providence, RI-based firm developing a DNA sequencing technology that employs silicon chips for rapid electronic detection of DNA sequences. —Boston-based Battery Ventures sold … Continue reading “Luminus Devices Nabs $19M, Aveo Sets IPO Range, Thermo Fisher Scientific Reportedly Makes $6 B Move on Millipore, & More Boston-Area Deals News”
EveryScape Adds $6M, Eyes Asia
EveryScape announced it has raised $6 million in a Series C funding round led by SK Telecom Americas, a division of Korean mobile operator SK Telecom (NYSE: [[ticker:SKM]]), and joined by return investors Draper Fisher Jurvetson and Dace Ventures. Waltham, MA-based EveryScape, which provides navigable, 360-degree views of metropolitan, suburban, and rural areas, will use … Continue reading “EveryScape Adds $6M, Eyes Asia”